Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Man-Seong Park
Affiliation
Korea University College of Medicine
ORCID
Career Start Year
2001
Papers
118
H Index
24
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36669564
Comparison of the clinical and virological characteristics of SARS-CoV-2 Omicron BA.1/BA.2 and omicron BA.5 variants: A prospective cohort study.
J Infect
2023
37702580
A natural variation in the RNA polymerase of severe fever with thrombocytopenia syndrome virus enhances viral replication and in vivo virulence.
J Med Virol
2023
37680469
Molecular evolution and targeted recombination of SARS-CoV-2 in South Korea.
iScience
2023
37563335
Stabilization of RNA G-quadruplexes in the SARS-CoV-2 genome inhibits viral infection via translational suppression.
Arch Pharm Res
2023
37244782
Corrigendum to "Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection" [J Infect 85 (2022) e69-e71].
J Infect
2023
36973368
Performance evaluation of newly developed surrogate virus neutralization tests for detecting neutralizing antibodies against SARS-CoV-2.
Sci Rep
2023
37003909
Comparison of culture-competent virus shedding duration of SARS-CoV-2 Omicron variant in regard to vaccination status: A prospective cohort study.
Vaccine
2023
36960070
Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection.
Front Immunol
2023
36856164
In vitro and in vivo suppression of SARS-CoV-2 replication by a modified, short, cell-penetrating peptide targeting the C-terminal domain of the viral spike protein.
J Med Virol
2023
36634813
Establishment of multicenter COVID-19 therapeutics preclinical test system in Republic of Korea.
Pulm Pharmacol Ther
2023
36458559
Comparison of secondary attack rate and viable virus shedding between patients with SARS-CoV-2 Delta and Omicron variants: A prospective cohort study.
J Med Virol
2023
34400343
Diagnostic usefulness of subgenomic RNA detection of viable SARS-CoV-2 in patients with COVID-19.
Clin Microbiol Infect
2022
35842468
Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants.
Sci Rep
2022
35351541
Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment.
J Infect
2022
35839776
Amelioration of SARS-CoV-2 infection by ANO6 phospholipid scramblase inhibition.
Cell Rep
2022
35705135
Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection.
J Infect
2022
35608859
Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals.
JAMA Netw Open
2022
35765097
Laboratory information management system for COVID-19 non-clinical efficacy trial data.
Lab Anim Res
2022
35502502
Nosocomial Outbreak by Delta Variant From a Fully Vaccinated Patient.
J Korean Med Sci
2022
36680068
Production of a Monoclonal Antibody to the Nucleocapsid Protein of SARS-CoV-2 and Its Application to ELISA-Based Detection Methods with Broad Specificity by Combined Use of Detector Antibodies.
Viruses
2022
36215268
Comparison of vaccination efficacy using live or ultraviolet-inactivated influenza viruses introduced by different routes in a mouse model.
PLoS One
2022
36341265
Daily, self-test rapid antigen test to assess SARS-CoV-2 viability in de-isolation of patients with COVID-19.
Front Med (Lausanne)
2022
35931794
Kinetics of neutralizing antibodies against SARS-CoV-2 infection according to sex, age, and disease severity.
Sci Rep
2022
36298836
Serological Evidence of Severe Fever with Thrombocytopenia Syndrome Virus and IgM Positivity Were Identified in Healthy Residents in Vietnam.
Viruses
2022
36125147
Clinical Application of a Solid-Phase Assay for SARS-CoV-2 IgG to Predict a Neutralizing Antibody Titer.
Clin Lab
2022
36324270
Temporal Transcriptome Analysis of SARS-CoV-2-Infected Lung and Spleen in Human ACE2-Transgenic Mice.
Mol Cells
2022
36223658
Clinical scoring system to predict viable viral shedding in patients with COVID-19.
J Clin Virol
2022
36192424
Author Correction: Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants.
Sci Rep
2022
36222118
Comparison of the pathogenesis of SARS-CoV-2 infection in K18-hACE2 mouse and Syrian golden hamster models.
Dis Model Mech
2022
35881005
The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2.
Science
2022
36217571
Evaluation of In-Hospital Cluster of COVID-19 Associated With a Patient With Prolonged Viral Shedding Using Whole-Genome Sequencing.
J Korean Med Sci
2022
33685546
Feasibility of ultraviolet light-emitting diode irradiation robot for terminal decontamination of coronavirus disease 2019 (COVID-19) patient rooms.
Infect Control Hosp Epidemiol
2022
35235179
Insights into the immune responses of SARS-CoV-2 in relation to COVID-19 vaccines.
J Microbiol
2022
35023551
COVID-19 Cluster Linked to Aerosol Transmission of SARS-CoV-2 via Floor Drains.
J Infect Dis
2022
33436577
A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein.
Nat Commun
2021
33875625
Multifactorial Traits of SARS-CoV-2 Cell Entry Related to Diverse Host Proteases and Proteins.
Biomol Ther (Seoul)
2021
33731494
Antiviral Efficacy of Pralatrexate against SARS-CoV-2.
Biomol Ther (Seoul)
2021
33617577
Human infection with Seoul orthohantavirus in Korea, 2019.
PLoS Negl Trop Dis
2021
33783327
TRIM28 functions as a negative regulator of aggresome formation.
Autophagy
2021
33503337
Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19.
N Engl J Med
2021
33664866
MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein.
Theranostics
2021
33808752
Specific Detection of Influenza A and B Viruses by CRISPR-Cas12a-Based Assay.
Biosensors (Basel)
2021
34943430
Performance Evaluation of the BZ COVID-19 Neutralizing Antibody Test for the Culture-Free and Rapid Detection of SARS-CoV-2 Neutralizing Antibodies.
Diagnostics (Basel)
2021
34868052
MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants.
Front Immunol
2021
34433827
A high-resolution temporal atlas of the SARS-CoV-2 translatome and transcriptome.
Nat Commun
2021
34407077
Seroepidemiologic survey of emerging vector-borne infections in South Korean forest/field workers.
PLoS Negl Trop Dis
2021
34427062
Frequent Occurrence of SARS-CoV-2 Transmission among Non-close Contacts Exposed to COVID-19 Patients.
J Korean Med Sci
2021
34834940
Dynamics of Viral Shedding and Symptoms in Patients with Asymptomatic or Mild COVID-19.
Viruses
2021
34216126
Nosocomial Outbreak of COVID-19 in a Hematologic Ward.
Infect Chemother
2021
34099809
Effective inactivated influenza vaccine for the elderly using a single-stranded RNA-based adjuvant.
Sci Rep
2021
1 - 50 of 118
Column Actions
Search
Recommended Authors
Raveen Rathnasinghe
Icahn School of Medicine at Mount Sinai New York
Career Start Year
2015
Number of shared co-authors
8
Hongjie Xia
University of Texas Medical Branch
Career Start Year
2012
Number of shared co-authors
0
Teresa Aydillo
Icahn School of Medicine at Mount Sinai
Career Start Year
2011
Number of shared co-authors
9
Shashank Tripathi
Indian Institute of Science
Career Start Year
2011
Number of shared co-authors
10
Xin Yin
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
2010
Number of shared co-authors
4
James Zengel
Stanford University School of Medicine
Career Start Year
2010
Number of shared co-authors
0
Michael Schotsaert
Icahn School of Medicine at Mount Sinai
Career Start Year
2008
Number of shared co-authors
10
Vineet D Menachery
University of Texas Medical Branch
Career Start Year
2008
Number of shared co-authors
0
Qiyun Zhu
Biodesign Center for Fundamental and Applied Microbiomics, Arizona State University
Career Start Year
2007
Number of shared co-authors
2
Yasuko Hatta
FluGen Inc.
Career Start Year
2007
Number of shared co-authors
0
Shufang Fan
Influenza Research Institute, University of Wisconsin
Career Start Year
2006
Number of shared co-authors
2
Mila B Ortigoza
NYU Grossman School of Medicine
Career Start Year
2006
Number of shared co-authors
5
Nicholas S Heaton
Duke University School of Medicine
Career Start Year
2006
Number of shared co-authors
5
Chengjun Li
Harbin Veterinary Research Institute
Career Start Year
2005
Number of shared co-authors
0
Sudhakar Agnihothram
National Center for Toxicological Research
Career Start Year
2005
Number of shared co-authors
0
Guojun Wang
College of Life Sciences, Inner Mongolia University
Career Start Year
2005
Number of shared co-authors
5
Silke Stertz
Institute of Medical Virology, University of Zurich
Career Start Year
2004
Number of shared co-authors
7
Emmie de Wit
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year
2004
Number of shared co-authors
3
Wan-Mui Chan
School of Clinical Medicine, The University of Hong Kong
Career Start Year
2003
Number of shared co-authors
0
Balaji Manicassamy
University of Iowa
Career Start Year
2002
Number of shared co-authors
8
Randy A Albrecht
Icahn School of Medicine at Mount Sinai
Career Start Year
2001
Number of shared co-authors
14
Masato Hatta
Influenza Research Institute, University of Wisconsin-Madison
Career Start Year
2000
Number of shared co-authors
2
Rong Hai
University of California riverside
Career Start Year
1999
Number of shared co-authors
8
Gabriele Neumann
Influenza Research Institute, University of Wisconsin-Madison
Career Start Year
1993
Number of shared co-authors
3
Boyd L Yount
University of North Carolina at Chapel Hill
Career Start Year
1993
Number of shared co-authors
2
Ted M Ross
Center for Vaccines and Immunology, University of Georgia
Career Start Year
1991
Number of shared co-authors
2
Terrence M Tumpey
Centers for Disease Control and Prevention.
Career Start Year
1989
Number of shared co-authors
6
Bart L Haagmans
Erasmus Medical Center
Career Start Year
1986
Number of shared co-authors
6
Ralph S Baric
University of North Carolina
Career Start Year
1981
Number of shared co-authors
4
Yoshihiro Kawaoka
Influenza Research Institute, University of Wisconsin
Career Start Year
1979
Number of shared co-authors
5
row(s) 1 - 30 of 30
Collaborators
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers
11
Donghwan Kim
Korea Food Research Institute
Co-authored papers
8
Peter Palese
Icahn School of Medicine at Mount Sinai
Co-authored papers
6
Philippe Lemey
Rega Institute, Laboratory of Clinical and Evolutionary Virology
Co-authored papers
4
Je Kyung Seong
Seoul National University
Co-authored papers
4
Christopher F Basler
Icahn School of Medicine at Mount Sinai
Co-authored papers
3
Edward C Holmes
Sydney Institute for Infectious Diseases, The University of Sydney
Co-authored papers
1
Vinod R M T Balasubramaniam
Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia
Co-authored papers
1
Heedo Park
Institute for Viral Diseases, College of Medicine, Korea University
Co-authored papers
1
Andrew Magee
David Geffen School of Medicine, University of California los angeles
Co-authored papers
1
Tetyana I Vasylyeva
University of California
Co-authored papers
1
Ignacio Mena
Icahn School of Medicine at Mount Sinai
Co-authored papers
1
Niema Moshiri
Bonita Vista High School, University of California San Diego, University of California, San Diego
Co-authored papers
1
Scott Hughes
Co-authored papers
1
Jennifer L Havens
University of California
Co-authored papers
1
Kristian G Andersen
The Scripps Research Institute
Co-authored papers
1
Stuart C Sealfon
Icahn School of Medicine at Mount Sinai
Co-authored papers
1
Qinshan Gao
Merck & Co., Inc.
Co-authored papers
1
Carles Mart??nez-Romero
Icahn School of Medicine at Mount Sinai
Co-authored papers
1
Jade C Wang
Co-authored papers
1
Mohd Noor Mat Isa
Malaysia Genome and Vaccine Institute, National Institute of Biotechnology Malaysia
Co-authored papers
1
Yusuf Muhammad Noor
Malaysia Genome and Vaccine Institute
Co-authored papers
1
Robert F Garry
Tulane University School of Medicine
Co-authored papers
1
Katherine Izhikevich
University of California
Co-authored papers
1
Lorena Mariana Malpica Serrano
University of Arizona
Co-authored papers
1
Joel O Wertheim
University of California
Co-authored papers
1
Jonathan E Pekar
University of California San Diego
Co-authored papers
1
Karthik Gangavarapu
the Scripps Research Institute
Co-authored papers
1
Sungho Won
Co-authored papers
1
Megan L Shaw
Icahn School of Medicine at Mount Sinai
Co-authored papers
1
1 - 30